
The CGD Association of America (CGDAA) was founded in 2019 to advocate for patients and X-linked female CGD carriers with Chronic Granulomatous Disease (CGD). We have the largest community of patients and X-linked female carriers with CGD in the world. Currently, our database has 550 patient contacts and more than 200 CGD physician specialists/influencers worldwide.
Thanks to the CGDAA’s reputation as a trusted resource, the organization’s database has become the largest in the world; this robust collection of patient and carrier data has enabled important IRB-approved, patient-centered surveys and studies. In addition to funding important research, our organization also publishes a monthly e-newsletter for the community and holds well-attended online events to help connect our rare community and provide education.
Given the rarity of CGD, the disease can feel isolating. The CGDAA is committed to helping patients and carriers know they’re not alone.
Ongoing projects:• The CGDAA has provided a $25,000 research grant to the Primary Immune Deficiency Consortium to investigate the health issues facing female X-linked carriers of CGD and the long-term post-transplant outcomes for patients with CGD.
.The CGDAA is committed to helping patients and carriers know they’re not alone.
About Felicia Morton, Communications Director
Felicia Morton is a seasoned healthcare communications professional dedicated to advocating for patients with rare diseases and primary immune deficiencies. In her work with the CGDAA, she drives communication strategy, digital content, community building, events, and conferences—while providing timely insights on advances in immunology, immunotherapy, and gene therapy. She also spearheads IRB-approved research and publishes studies that advance clinical understanding and support better patient outcomes.
A former journalist, Felicia has written for “The Wall Street Journal” and “The Washington Post.” Prior to joining CGDAA, she worked at leading public relations agencies, including Manning Selvage & Lee and Golin Harris, supporting major healthcare and wellness brands such as Procter & Gamble, Novo Nordisk, Roche, Eli Lilly, Merck, Pfizer, The Body Shop, and Laura Mercier.
Anissa began her communications role at the CGDAA in 2020. She is thankful for the opportunity to use her marketing background to help progress the CGDAA's mission and connecting people together.

National Institutes of Health
Chief, Genetic Immunotherapy Section
Deputy Chief, Laboratory of Clinical Immunology and Microbiology
National Institute of Allergy and Infectious Diseases, National Institutes of Health

Chief of the Division of Allergy and Immunology, Children's Hospital of Philadelphia

Adjunct Associate Professor John's Hopkins University and Attending Physician, Orlando Health Arnold Palmer Hospital for Children

Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Fred M. Saigh Distinguished Chair of Pediatric Research Professor of Pediatrics , Washington University School of Medicine St. Louis Children’s Hospital

FACAAI Chief, Immunology, Allergy and Rheumatology at Memorial Healthcare System, Joe DiMaggio Children’s Hospital

Lydia Sancho
Erynn Hunkapiller

Felicia B. Morton
Denise Proffitt
Barbara D. Morton

Robert Karp, patient with CGD
Scott Vogel, former CGD patient after successful transplant
Carla Dean, autosomal patient with CGD

Maren Chamorro
Gina Continenza
Kiron Dhalilwal
Alia Naffouj
Marianne Rørholt (Norway)
CGD Association of America
3300 S. Dixie Hwy, Ste. 1-266, West Palm Beach, FL, 33405
Copyright © 2018 Chronic Granulomatous Disease Association of America - All Rights Reserved. Sec501(c)3 tax-exempt non-profit organization
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The contents of the CGD Association of America site, such as text, graphics, images, and other material contained on the CGDAA Site (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding CGD or any medical condition.